Investors and Media | May 30, 2018
Casma Therapeutics Co-Founder Reports Health Benefits of Increased Autophagy in Mammals in Nature Publication
CAMBRIDGE, Mass., May 30, 2018 — Casma Therapeutics Inc., a biotechnology company harnessing the natural cellular process of autophagy to design powerful new medicines, today announced the publication of a landmark paper by scientific co-founder Beth Levine describing the health and lifespan benefits of increased autophagy in a mouse model. The study, published in Nature, describes observations […]